Aidoc raises $150M with Nvidia backing as AI pushes faster diagnosis

Aidoc, an AI company that helps medical teams make real-time clinical decisions, has raised $150 million at a valuation higher than its previous round, bringing its total funding to $370 million to date.

Full list of Israeli high-tech funding rounds in 2025

The latest funding round marks a significant milestone for the company, with NVentures, NVIDIA’s investment arm, joining as an investor for the first time. The round was co-led by General Catalyst and Square Peg, alongside several major U.S. health systems. Approximately $40 million of the funding was raised through a revolving credit facility. The capital will be used to accelerate the development of CARE, Aidoc’s new Foundation Model, which underpins two AI products recently approved by the FDA and adds to dozens of prior approvals.

In an interview with Calcalist, Michael Braginsky, Aidoc’s CTO, said: “We saw an opportunity with our new technology to move faster. With our previous technology, we tackled one disease at a time. Now, the mapping rate is significantly faster. What used to take decades now takes far less time, we can build each algorithm ten times faster. We used to develop one or two algorithms a year; this year alone, we’ve created fifteen, providing doctors with more comprehensive insights into patient conditions. Revenue from the new technology already surpasses everything we’ve done in recent years. Within a year, we expect to exceed the total of the last nine years.”

“NVIDIA saw the results of our research, which lasted more than two years. They’re all in, because this is a huge boost for AI,” Braginsky added. “They’re looking for new markets and applications. The funding will help us build this new technology and expand the platform to enable more AI companies to plug in. We already have seven AI companies on our platform.”

Aidoc was founded in 2016 by its CEO Elad Walach, CTO Michael Braginsky, and VP of R&D and CISO Guy Reiner, all three graduates of the IDF’s Talpiot program.

Aidoc operates one of the world’s most advanced AI research and development centers for healthcare. Its platform is installed in thousands of hospitals worldwide, including most hospitals in Israel, and offers FDA-cleared products that detect and alert clinicians in real time about life-threatening conditions such as brain hemorrhages, aneurysms, fractures, aortic aneurysms, pulmonary embolisms, strokes, and more. The company currently helps treat more than 45 million patients each year and expects to double that figure to around 100 million within three years.